PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ETON vs. ACET
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ETON and ACET is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

ETON vs. ACET - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eton Pharmaceuticals Inc (ETON) and Adicet Bio, Inc. (ACET). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%100.00%150.00%200.00%SeptemberOctoberNovemberDecember2025
182.88%
-98.85%
ETON
ACET

Key characteristics

Sharpe Ratio

ETON:

4.72

ACET:

-0.96

Sortino Ratio

ETON:

4.42

ACET:

-1.74

Omega Ratio

ETON:

1.62

ACET:

0.81

Calmar Ratio

ETON:

3.92

ACET:

-0.70

Martin Ratio

ETON:

16.01

ACET:

-1.23

Ulcer Index

ETON:

17.05%

ACET:

56.20%

Daily Std Dev

ETON:

57.95%

ACET:

72.19%

Max Drawdown

ETON:

-79.94%

ACET:

-99.41%

Current Drawdown

ETON:

0.00%

ACET:

-99.39%

Fundamentals

Market Cap

ETON:

$236.92M

ACET:

$72.92M

EPS

ETON:

-$0.26

ACET:

-$1.70

Total Revenue (TTM)

ETON:

$27.36M

ACET:

$0.00

Gross Profit (TTM)

ETON:

$16.94M

ACET:

-$3.25M

EBITDA (TTM)

ETON:

-$2.70M

ACET:

-$83.55M

Returns By Period

In the year-to-date period, ETON achieves a 32.73% return, which is significantly higher than ACET's -8.00% return.


ETON

YTD

32.73%

1M

36.00%

6M

393.85%

1Y

293.76%

5Y*

21.11%

10Y*

N/A

ACET

YTD

-8.00%

1M

-10.85%

6M

-38.54%

1Y

-70.50%

5Y*

-37.84%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ETON vs. ACET — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ETON
The Risk-Adjusted Performance Rank of ETON is 9797
Overall Rank
The Sharpe Ratio Rank of ETON is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of ETON is 9797
Sortino Ratio Rank
The Omega Ratio Rank of ETON is 9797
Omega Ratio Rank
The Calmar Ratio Rank of ETON is 9797
Calmar Ratio Rank
The Martin Ratio Rank of ETON is 9696
Martin Ratio Rank

ACET
The Risk-Adjusted Performance Rank of ACET is 77
Overall Rank
The Sharpe Ratio Rank of ACET is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of ACET is 33
Sortino Ratio Rank
The Omega Ratio Rank of ACET is 66
Omega Ratio Rank
The Calmar Ratio Rank of ACET is 88
Calmar Ratio Rank
The Martin Ratio Rank of ACET is 1414
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ETON vs. ACET - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Eton Pharmaceuticals Inc (ETON) and Adicet Bio, Inc. (ACET). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ETON, currently valued at 4.72, compared to the broader market-2.000.002.004.72-0.96
The chart of Sortino ratio for ETON, currently valued at 4.42, compared to the broader market-4.00-2.000.002.004.004.42-1.74
The chart of Omega ratio for ETON, currently valued at 1.62, compared to the broader market0.501.001.502.001.620.81
The chart of Calmar ratio for ETON, currently valued at 3.92, compared to the broader market0.002.004.006.003.92-0.70
The chart of Martin ratio for ETON, currently valued at 16.01, compared to the broader market0.0010.0020.0030.0016.01-1.23
ETON
ACET

The current ETON Sharpe Ratio is 4.72, which is higher than the ACET Sharpe Ratio of -0.96. The chart below compares the historical Sharpe Ratios of ETON and ACET, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.00SeptemberOctoberNovemberDecember2025
4.72
-0.96
ETON
ACET

Dividends

ETON vs. ACET - Dividend Comparison

Neither ETON nor ACET has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ETON vs. ACET - Drawdown Comparison

The maximum ETON drawdown since its inception was -79.94%, smaller than the maximum ACET drawdown of -99.41%. Use the drawdown chart below to compare losses from any high point for ETON and ACET. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember20250
-99.06%
ETON
ACET

Volatility

ETON vs. ACET - Volatility Comparison

Eton Pharmaceuticals Inc (ETON) has a higher volatility of 24.71% compared to Adicet Bio, Inc. (ACET) at 19.24%. This indicates that ETON's price experiences larger fluctuations and is considered to be riskier than ACET based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025
24.71%
19.24%
ETON
ACET

Financials

ETON vs. ACET - Financials Comparison

This section allows you to compare key financial metrics between Eton Pharmaceuticals Inc and Adicet Bio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab